Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date | Tue May 18 EDT - Thu May 20 EDT (about 4 years ago) |
Location | Virtual |
Region | Americas |
Join us this May, after federal reporting deadlines have passed, for a timely conversation on updates in transparency and aggregate spend to allow for best practice sharing and benchmarking with industry peers. Immerse yourself in the regulations, technology, major trends, analytics and compliance insights to improve your transparency programs, both in the U.S. and around the world.
Critical Topics for Conversation:
• Government Guidance Updates Regarding OIG Speaker Programs Fraud Alert
• Lessons Learned, Challenges Overcome and Adaptations Made in 2020 to Ensure Continuity
• Data Fluctuations as a Result of the COVID-19 Pandemic
• Practical Implications of Sunshine Act Expansion and the Inclusion of Newly Covered Recipients
• Global Compliance Risks in an Interconnected World
• Dispute Management and Resolution
Who should attend?
You will benefit from this conference if you are a manager, director or executive at a bio/pharmaceutical or medical device company with responsibilities or involvement in the following areas:
• Compliance
• Ethics
• Legal
• Transparency Reporting
• Aggregate Spend
• HCP Engagement/Interactions
• Commercial
• Global Compliance/Transparency
2021 Speakers
Bobby Balles
Senior Manager, Government Accountability, Novo Nordisk
Brian Bohnenkamp
Partner, FDA & Life Sciences, King & Spalding LLP
Tammy Brintzinghoffer
Director, Global Transparency Reporting, Johnson & Johnson
Terra Buckley
Vice President, Head of Compliance Advisory Services, MedPro Systems
Emily Cunningham
Associate Principal & Transcend Lead, IQVIA
Michelle Dague
Director, Compliance, RedHill Biopharma Ltd.
Bill Friedrich, MBA
Associate Director, Compliance, Hikma Pharmaceuticals
Johan Holm
Director, U.S. Transparency, Managed Services, IQVIA
Melissa LaFrain
Director, Global Transparency Operations, AstraZeneca
Kathryn Laquidara
Conference Producer, Informa Connect
Mariko Motohashi
Associate Director, Commercial Compliance & Operations, Theravance Biopharma
Sharon Muscato
Director, Transparency & Compliance Operations, Alexion Pharmaceuticals
Chelsea Ott
Regulatory & Compliance – Senior Associate, MedPro Systems, LLC
Mohammad Ovais
CEO, qordata
Viveca Parker
Assistant U.S. Attorney, U.S. Attorney’s Office for the Eastern District of Pennsylvania
Veronika Peleshchuk Fradlin
Acting Director, Division of Data & Informatics, Centers for Medicare and Medicaid Services (CMS)
Amie Phillips Pablo
Director, Ethics and Compliance, Novo Nordisk
Nikki Reeves
Partner, FDA & Life Sciences, King & Spalding LLP
Gretchen Reyes Cseplo
Director, Ethics, Risk & Compliance, Novartis
Brian Sharkey
Director, US Commercial Compliance & Ethics, Teva Pharmaceuticals
Steven Sharobem
Assistant U.S. Attorney, The United States Attorney’s Office for the District of Massachusetts
Karen Snyder, JD
Associate Director, U.S. Compliance, MorphoSys
Frank Spender
Senior Director, Compliance Services, IQVIA
Paul Steele
Director, Transparency Reporting, Sunovion Pharmaceuticals Inc.
Risa Stokes-Grassi
Deputy Director, Federal, State & Global Disclosure Management, Bayer U.S. LLC
David Walk
Assistant U.S. Attorney, U.S. Attorney’s Office District of New Jersey
2021 Sponsors
EDUCATIONAL SPONSOR:
• IQVIA
SUPPORTING SPONSORS:
• qordata
• MediSpend
• PwC
• MedPro Systems
• Potomac River Partners
• Vector Health
• S3 Comply
• Meetings & Events International